Back to results
US 8,026,098 B2Granted
Process for the removal of selectable marker gene sequences
AssigneeCobra Biologics Limited
InventorsRocky Marc Cranenburgh, Alexandra Elizabeth Bloor
Life of this patent
Estimating the term…
Abstract
The invention relates to a process for the removal of selectable marker gene sequences, in particular antibiotic gene sequences, from nucleic acid molecules. The invention further relates to the application of this process in the unlabelled integration and deletion of chromosomal genes and in controlling gene expression.
Claims18
A process for unlabelled nucleic acid integration into the chromosome of a prokaryotic cell comprising:
- introducing a linear DNA cassette into a prokaryotic cell, wherein said linear DNA cassette comprises:
- a selectable marker gene;
- two dif-like site-specific recombinase recognition sites flanking said selectable marker gene;
- and
- two regions flanking said dif-like site-specific recombinase recognition sites which are homologous to the two regions flanking the site of integration in the chromosome of the cell;
- culturing said cell under conditions such that the linear DNA cassette is integrated into the cell chromosome by homologous recombination to produce a cell comprising said DNA cassette;
- and
- culturing said cell comprising said DNA cassette under conditions such that an endogenous site-specific recombinase encoded by the chromosome of the cell acts to excise the selectable marker gene by site-specific recombination between the dif-like site-specific recombinase recognition sites.
5 more elements
Dependencies are inferred from the claim text.